Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Cholestasis in Premature Infants Using SMOFLipid®

NCT01585935 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01585935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01585935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Cholestasis in Premature Infants Using SMOFLipid®
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2012
Completion date
November 13, 2017
Enrollment
230 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholestasis, psychomotor disorders, developmental